TuHURA Biosciences, Inc.

TuHURA Biosciences Reports Third Quarter 2026 Financial Results and Provides a Corporate Update

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome…